English  |  正體中文  |  简体中文  |  總筆數 :2852366  
造訪人次 :  44969397    線上人數 :  1805
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"wu j y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 231-255 / 599 (共24頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-12-16T02:25:18Z Genetic epidemiological study doesn't support GLA IVS4?+?919G?>?A variant is a significant mutation in Fabry disease Chiang H.-L.;Wang N.H.-H.;Song I.-W.;Chang C.-P.;Wen M.-S.;Chien Y.-H.;Wuh-Liang Hwu;Tsai F.-J.;Chen Y.-T.;Wu J.-Y.; Chiang H.-L.; Wang N.H.-H.; Song I.-W.; Chang C.-P.; Wen M.-S.; Chien Y.-H.; WUH-LIANG HWU; Tsai F.-J.; Chen Y.-T.; Wu J.-Y.
臺大學術典藏 2020-12-15T07:42:11Z Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease Khor C.C.;Davila S.;Breunis W.B.;Lee Y.-C.;Shimizu C.;Wright V.J.;Yeung R.S.M.;Tan D.E.K.;Sim K.S.;Wang J.J.;Wong T.Y.;Pang J.;Mitchell P.;Cimaz R.;Dahdah N.;Cheung Y.-F.;Huang G.-Y.;Yang W.;Park I.-S.;Lee J.-K.;Wu J.-Y.;Levin M.;Burns J.C.;Burgner D.;Kuijpers T.W.;Hibberd M.L.;Lau Y.-L.;Zhang J.;Ma X.-J.;Liu F.;Wu L.;Yoo J.-J.;Hong S.-J.;Kim K.-J.;Kim J.-J.;Park Y.-M.;Hong Y.M.;Sohn S.;Jang G.Y.;Ha K.-S.;Nam H.-K.;Byeon J.-H.;Yun S.W.;Han M.K.;Lee K.-Y.;Hwang J.-Y.;Rhim J.-W.;Song M.S.;Lee H.-D.;Kim D.S.;Lee J.-M.;Chang J.-S.;Tsai F.-J.;Liang C.-D.;Chen M.-R.;Chi H.;Chiu N.-C.;Huang F.-Y.;Luan-Yin Chang;Huang L.-M.;Kuo H.-C.;Huang K.-P.;Lee M.-L.;Hwang B.;Huang Y.-C.;Lee P.-C.;Odam M.;Christiansen F.T.;Witt C.;Goldwater P.;Curtis N.;Palasanthiran P.;Ziegler J.;Nissen M.;Nourse C.;Kuipers I.M.;Ottenkamp J.J.;Geissler J.;Biezeveld M.;Tacke C.;Filippini L.;Brogan P.;Klein N.;Shah V.;Dillon M.;Booy R.;Shingadia D.;Bose A.;Mukasa T.;Tulloh R.;Michie C.;Newburger J.W.;Baker A.L.;Rowley A.H.;Shulman S.T.;Mason W.;Takahashi M.;Melish M.E.;Tremoulet A.H.;Viswanathan A.;Rochtchina E.;Attia J.;Scott R.;Holliday E.;Harrap S.; Khor C.C.; Davila S.; Breunis W.B.; Lee Y.-C.; Shimizu C.; Wright V.J.; Yeung R.S.M.; Tan D.E.K.; Sim K.S.; Wang J.J.; Wong T.Y.; Pang J.; Mitchell P.; Cimaz R.; Dahdah N.; Cheung Y.-F.; Huang G.-Y.; Yang W.; Park I.-S.; Lee J.-K.; Wu J.-Y.; Levin M.; Burns J.C.; Burgner D.; Kuijpers T.W.; Hibberd M.L.; Lau Y.-L.; Zhang J.; Ma X.-J.; Liu F.; Wu L.; Yoo J.-J.; Hong S.-J.; Kim K.-J.; Kim J.-J.; Park Y.-M.; Hong Y.M.; Sohn S.; Jang G.Y.; Ha K.-S.; Nam H.-K.; Byeon J.-H.; Yun S.W.; Han M.K.; Lee K.-Y.; Hwang J.-Y.; Rhim J.-W.; Song M.S.; Lee H.-D.; Kim D.S.; Lee J.-M.; Chang J.-S.; Tsai F.-J.; Liang C.-D.; Chen M.-R.; Chi H.; Chiu N.-C.; Huang F.-Y.; LUAN-YIN CHANG; Huang L.-M.; Kuo H.-C.; Huang K.-P.; Lee M.-L.; Hwang B.; Huang Y.-C.; Lee P.-C.; Odam M.; Christiansen F.T.; Witt C.; Goldwater P.; Curtis N.; Palasanthiran P.; Ziegler J.; Nissen M.; Nourse C.; Kuipers I.M.; Ottenkamp J.J.; Geissler J.; Biezeveld M.; Tacke C.; Filippini L.; Brogan P.; Klein N.; Shah V.; Dillon M.; Booy R.; Shingadia D.; Bose A.; Mukasa T.; Tulloh R.; Michie C.; Newburger J.W.; Baker A.L.; Rowley A.H.; Shulman S.T.; Mason W.; Takahashi M.; Melish M.E.; Tremoulet A.H.; Viswanathan A.; Rochtchina E.; Attia J.; Scott R.; Holliday E.; Harrap S.
臺大學術典藏 2020-12-15T07:42:09Z Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis Liang C.-D.; Chi H.; Huang F.-Y.; Lee M.-L.; Huang Y.-C.; Hwang B.; Chiu N.-C.; Hwang K.-P.; Lee P.-C.; Chang L.-C.; Liu Y.-M.; Chen Y.-J.; Chen C.-H.; Chen Y.-T.; Tsai F.-J.; Wu J.-Y.; Chen M.-R.; LUAN-YIN CHANG; Huang L.-M.; Chang J.-S.; Kuo H.-C.; Lee Y.-C.
臺大學術典藏 2020-12-09T01:38:25Z Diagnosis of aromatic l-amino acid decarboxylase deficiency by measuring 3-O-methyldopa concentrations in dried blood spots Chen P.-W.; NI-CHUNG LEE; Chien Y.-H.; Wu J.-Y.; Wang P.-C.; Hwu W.-L.
臺大學術典藏 2020-12-02T02:34:35Z Adrenal insufficiency in prolonged critical illness Wu J.-Y.; Hsu S.-C.; Ku S.-C.; Ho C.-C.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Hsu S.-C.; Ku S.-C.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:34Z Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Chang Y.-L.;Yu C.-J.;Shin J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:31Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:29Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:27Z The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis Wu J.-Y.; Kuo P.-H.; Fan P.-C.; Wu H.-D.; Shih F.-Y.; Pan-Chyr Yang; Wu J.-Y.; Kuo P.-H.; Fan P.-C.; Wu H.-D.; Shih F.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:24Z Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection Wu J.-Y.; Wu S.-G.; Sun H.-Y.; Kuo P.-H.; Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Sun H.-Y.; Kuo P.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:20Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer Wu J.-Y.;Shih J.-Y.;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:18Z Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer Wu J.-Y.;Yu C.-J.;Shih J.-Y.;Yang C.-H.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Shih J.-Y.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:17Z Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:10Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Chang Y.-C.;Hsu Y.-C.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:10Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:09Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.;Yu C.-J.;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:00Z TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma Lin J.-C.; Wu Y.-Y.; Wu J.-Y.; Lin T.-C.; Wu C.-T.; Chang Y.-L.; Jou Y.-S.; Hong T.-M.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:59Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:52Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:44Z Overcoming EGFR T790M-based tyrosine kinase inhibitor resistance with an allele-specific DNAzyme Lai W.-Y.;Chen C.-Y.;Yang S.-C.;Wu J.-Y.;Chang C.-J.;PAN-CHYR YANG;Peck K.; Lai W.-Y.; Chen C.-Y.; Yang S.-C.; Wu J.-Y.; Chang C.-J.; PAN-CHYR YANG; Peck K.
臺大學術典藏 2020-11-27T03:28:40Z Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chien-Chuan Chen; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.
臺大學術典藏 2020-11-27T03:28:39Z Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection Chen M.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; Wu M.-S.
臺大學術典藏 2020-11-27T03:28:39Z Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria Fang Y.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chien-Chuan Chen; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S.
臺大學術典藏 2020-11-27T03:28:39Z The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study Liou J.-M.; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2020-11-27T03:28:38Z Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Tsao F.-Y.; Liu T.-Y.; Hsieh C.-F.; Bair M.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Chien-Chuan Chen; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.

顯示項目 231-255 / 599 (共24頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目